Zinc »
PDB 3tg5-3tty »
3thb »
Zinc in PDB 3thb: Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor
Enzymatic activity of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor
All present enzymatic activity of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor:
2.7.11.21;
2.7.11.21;
Protein crystallography data
The structure of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor, PDB code: 3thb
was solved by
M.D.Sintchak,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
| Resolution Low / High (Å) | 50.00 / 2.50 |
| Space group | P 32 2 1 |
| Cell size a, b, c (Å), α, β, γ (°) | 67.668, 67.668, 154.684, 90.00, 90.00, 120.00 |
| R / Rfree (%) | 25 / 28.6 |
Other elements in 3thb:
The structure of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor also contains other interesting chemical elements:
| Chlorine | (Cl) | 1 atom |
Zinc Binding Sites:
The binding sites of Zinc atom in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor
(pdb code 3thb). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor, PDB code: 3thb:
In total only one binding site of Zinc was determined in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor, PDB code: 3thb:
Zinc binding site 1 out of 1 in 3thb
Go back to
Zinc Binding Sites List in 3thb
Zinc binding site 1 out
of 1 in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor
Mono view
Stereo pair view
Mono view
Stereo pair view
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor within 5.0Å range:
|
Reference:
M.O.Duffey,
T.J.Vos,
R.Adams,
J.Alley,
J.Anthony,
C.Barrett,
I.Bharathan,
D.Bowman,
N.J.Bump,
R.Chau,
C.Cullis,
D.L.Driscoll,
A.Elder,
N.Forsyth,
J.Frazer,
J.Guo,
L.Guo,
M.L.Hyer,
D.Janowick,
B.Kulkarni,
S.J.Lai,
K.Lasky,
G.Li,
J.Li,
D.Liao,
J.Little,
B.Peng,
M.G.Qian,
D.J.Reynolds,
M.Rezaei,
M.P.Scott,
T.B.Sells,
V.Shinde,
Q.J.Shi,
M.D.Sintchak,
F.Soucy,
K.T.Sprott,
S.G.Stroud,
M.Nestor,
I.Visiers,
G.Weatherhead,
Y.Ye,
N.D'amore.
Discovery of A Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905). J.Med.Chem. V. 55 197 2012.
ISSN: ISSN 0022-2623
PubMed: 22070629
DOI: 10.1021/JM2011172
Page generated: Sat Oct 26 16:34:50 2024
ISSN: ISSN 0022-2623
PubMed: 22070629
DOI: 10.1021/JM2011172
Last articles
Fe in 2YXOFe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
